TY - JOUR
T1 - Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the Proglide closure device
AU - Dimitriadis, Zisis
AU - Scholtz, Werner
AU - Ensminger, Stephan M.
AU - Piper, Cornelia
AU - Bitter, Thomas
AU - Wiemer, Marcus
AU - Vlachojannis, Marios
AU - Börgermann, Jochen
AU - Faber, Lothar
AU - Horstkotte, Dieter
AU - Gummert, Jan
AU - Scholtz, Smita
N1 - Publisher Copyright:
© 2017 Dimitriadis et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2017/8
Y1 - 2017/8
N2 - Objective Evaluation of the impact of the sheath diameter on vascular complications and mortality in transfemoral aortic valve implantation. Method Between 2012 and 2014, 183 patients underwent the procedure using a sheath diameter of 18–24 F. This collective was divided into two groups: group 1, with a sheath diameter of 18F (G1, n = 94), consisted of patients with 18F Medtronic Sentrant and 18 F Direct Flow sheaths, and group 2 with a sheath diameter of 19–24 F (G2, n = 89) consisted of patients with Edwards expandable e-sheath and Solopath sheaths. Perclose-Proglide® was used as a closure device in all patients. Results G1 had significantly more female patients (64.9% vs. 46.1% in G2, p = 0.01) and the average BMI was lower (26 ± 4.5% vs. 27.4 ± 4.7%, p = 0.03). There was no significant difference in the incidence of major and minor vascular complications (G1: 12.8% vs. G2: 12.4%, p = 0.9). 30-day mortality was similar in both groups (G1: 6.4 ± 2.5% [95% CI: 0.88–0.98], G2: 3.7 ± 1.9% [95% CI: 0.92–0.99]. The Kaplan Meier analysis of survival revealed no significant differences either. Conclusion The difference in sheath diameter had no effect on either incidence or severity of vascular complications. There was no impact on mortality either.
AB - Objective Evaluation of the impact of the sheath diameter on vascular complications and mortality in transfemoral aortic valve implantation. Method Between 2012 and 2014, 183 patients underwent the procedure using a sheath diameter of 18–24 F. This collective was divided into two groups: group 1, with a sheath diameter of 18F (G1, n = 94), consisted of patients with 18F Medtronic Sentrant and 18 F Direct Flow sheaths, and group 2 with a sheath diameter of 19–24 F (G2, n = 89) consisted of patients with Edwards expandable e-sheath and Solopath sheaths. Perclose-Proglide® was used as a closure device in all patients. Results G1 had significantly more female patients (64.9% vs. 46.1% in G2, p = 0.01) and the average BMI was lower (26 ± 4.5% vs. 27.4 ± 4.7%, p = 0.03). There was no significant difference in the incidence of major and minor vascular complications (G1: 12.8% vs. G2: 12.4%, p = 0.9). 30-day mortality was similar in both groups (G1: 6.4 ± 2.5% [95% CI: 0.88–0.98], G2: 3.7 ± 1.9% [95% CI: 0.92–0.99]. The Kaplan Meier analysis of survival revealed no significant differences either. Conclusion The difference in sheath diameter had no effect on either incidence or severity of vascular complications. There was no impact on mortality either.
UR - http://www.scopus.com/inward/record.url?scp=85028370555&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0183658
DO - 10.1371/journal.pone.0183658
M3 - Journal articles
C2 - 28837613
AN - SCOPUS:85028370555
VL - 12
JO - PLoS ONE
JF - PLoS ONE
IS - 8
M1 - e0183658
ER -